Laparoscopic adjustable gastric banding in patients with insulin-treated type 2 diabetes

Timothy M E Davis and Catherine Coleman
Med J Aust 2011; 194 (8): . || doi: 10.5694/j.1326-5377.2011.tb03044.x
Published online: 18 April 2011

To the Editor: Laparoscopic adjustable gastric banding (LAGB) is the most common bariatric surgery performed in Australia, and diabetic patients represent an important target population.1 In one of few trials in type 2 diabetes, 73% of 30 LAGB-treated obese patients reverted to normal glucose tolerance by 2 years, compared with 13% of 30 obese patients randomly assigned to treatment with changes to their lifestyle.2 These Australian data precipitated publicity implying that many people with type 2 diabetes were cured by LAGB.3,4 However, only recently diagnosed patients were recruited. The benefits of LAGB in those with diabetes of long duration (and usually with a substantial loss of pancreatic beta-cell function5) may not be as dramatic.

  • Timothy M E Davis
  • Catherine Coleman

  • University of Western Australia, Fremantle, WA.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.